newsfilter
← Latest News
GlobeNewswire·

Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference

Video webcast now available here TAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with